RAS/PI3K pathway mutations sensitise epithelial ovarian cancer cells to a PARP/NAMPT inhibitor combinationRAS/PI3K通路突变使上皮性卵巢癌细胞对PARP/NAMPT抑制剂组合产生敏感性Communications BiologyIF5.12025-12-190OA
Targeting RNA splicing factor RBM39 improves therapy responses in ovarian high-grade serous carcinomaCANCER RESEARCHIF16.62024-03-040PRE
Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinomaCELL REPORTSIF6.92023-10-0110OA
Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastomaNATURE COMMUNICATIONSIF15.72022-03-1636OAAI
The modulation of the phosphorylation status of NKCC1 in organ cultured bovine lenses: Implications for the regulation of fiber cell and overall lens volumeEXPERIMENTAL EYE RESEARCHIF2.72017-12-0110PREAI